Position
Fidelity in Tyra Biosciences, Inc.
Back to the book · All holders of TYRA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$49.3M$38.30 → $31.94
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 12.6K | $330.3K | — | — | — | 0.0% |
| Q1 2026 | 7.75M | $296.7M | $38.30 | $150.9K | $296.3M | 0.0% |
| Q2 2026 | 8.92M | $284.9M | $31.94 | −$49.3M | $37.5M | 0.0% |